Page last updated: 2024-08-23

zidovudine and ic9564

zidovudine has been researched along with ic9564 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CH; Kashiwada, Y; Lee, KH; Sun, IC; Wang, HK; Wu, JH1
Chang, FR; Chen, CH; Huang, L; Kashiwada, Y; Lee, KH; Sakurai, Y; Yu, D1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Allaway, GP; Chen, CH; Huang, L; Lee, KH; Morris-Natschke, SL; Nitz, TJ; Qian, K; Reddick, M; Salzwedel, K; Yu, D1
Chen, CH; Dang, Z; Ho, P; Huang, L; Lai, W; Lee, KH; Qian, K1
Lee, KH1

Reviews

1 review(s) available for zidovudine and ic9564

ArticleYear
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
    Journal of natural products, 2010, Mar-26, Volume: 73, Issue:3

    Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal

2010

Other Studies

5 other study(ies) available for zidovudine and ic9564

ArticleYear
Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.
    Journal of medicinal chemistry, 2002, Sep-12, Volume: 45, Issue:19

    Topics: Amides; Animals; Anti-HIV Agents; Betulinic Acid; Chlorocebus aethiops; COS Cells; HIV Fusion Inhibitors; HIV-1; Leucine; Membrane Fusion; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes

2002
Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.
    Journal of medicinal chemistry, 2006, Sep-07, Volume: 49, Issue:18

    Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Protease Inhibitors; HIV-1; Humans; Lymphocytes; Oleanolic Acid; Structure-Activity Relationship

2006
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.
    Journal of medicinal chemistry, 2009, May-28, Volume: 52, Issue:10

    Topics: Anti-HIV Agents; Betulinic Acid; Drug Design; Drug Stability; Humans; Inhibitory Concentration 50; Microsomes, Liver; Pentacyclic Triterpenes; Solubility; Structure-Activity Relationship; Triterpenes

2009
Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: Anti-HIV Agents; Betulinic Acid; Cell Line; Dose-Response Relationship, Drug; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Pentacyclic Triterpenes; Triterpenes

2009
chemdatabank.com